With Bruker’s shares up 31 percent, Invitrogen’s ascending 26 percent, and PerkinElmer’s climbing 20 percent, the BioCommerce Week Index to the multiplatform molecular biology-tools sector has grown 9 percent in the 12-week period ended Nov. 22.

The index, a weekly compilation of the share prices of 15 selected molecular biology tool vendors that offer a diversified selection of products, serves as a measure and a benchmark of the industry’s growth.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.